Daniel Stetson

Acquired EGFR C797S mutation mediates resistance to AZD9291 in non–small cell lung cancer harboring EGFR T790M

Kenneth S. Thress, Cloud P. Paweletz, Enriqueta Felip et al. · Nature Medicine · 2015 · 1.5K citations · Full text

Medicine, Molecular Biology, Oncology +11

Osimertinib As First-Line Treatment of <i>EGFR</i> Mutation–Positive Advanced Non–Small-Cell Lung Cancer

Suresh S. Ramalingam, James Chih‐Hsin Yang, Chee Khoon Lee et al. · Journal of Clinical Oncology · 2017 · 536 citations

Medicine, Oncology, Pharmacology +14

Capivasertib Plus Paclitaxel Versus Placebo Plus Paclitaxel As First-Line Therapy for Metastatic Triple-Negative Breast Cancer: The PAKT Trial

Peter Schmid, Jacinta Abraham, Stephen Chan et al. · Journal of Clinical Oncology · 2019 · 389 citations · Full text

Medicine, Oncology, Pharmacology +16

Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA

Christopher Abbosh, Alexander M. Frankell, Thomas Harrison et al. · Nature · 2023 · 343 citations · Full text

Medicine, Cancer Biology, Oncology +12

Analysis of Ras-Induced Overproliferation in Drosophila Hemocytes

Hesarghatta Shyamasunder Asha, István Nagy, Gábor G. Kovács et al. · Genetics · 2003 · 304 citations

Life Sciences, Genetics, Molecular Genetics +17